Tatsunori Goto
Nagoya, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications
Asciminib Provides Better Efficacy and Favorable Safety and Tolerability Against Investigator-Selected Tyrosine Kinase Inhibitors in East Asian Patients With Newly Diagnosed Chronic Myeloid Leukemia: Results From a Subgroup Analysis of the Pivotal ASC4FIRST Study.
Journal: Cancer medicine
Published: March 20, 2026
Ruxolitinib-associated pulmonary alveolar proteinosis successfully managed by switching to belumosudil in chronic graft-versus-host disease.
Journal: Blood cell therapy
Published: March 18, 2026
Ianalumab plus Eltrombopag in Immune Thrombocytopenia.
Journal: The New England journal of medicine
Published: December 09, 2025
Peripheral blood UBA1 variant burden predicts poor outcomes in VEXAS syndrome: a nationwide prospective study.
Journal: Annals of the rheumatic diseases
Published: October 27, 2025
Percentage of CD56+ monocytes at neutrophil engraftment is associated with the incidence of acute graft-versus-host disease.
Journal: Annals of hematology
Published: July 01, 2025
Real-world outcomes of venetoclax and azacitidine in Japanese patients with newly diagnosed acute myeloid leukemia (VENUS study).
Journal: International journal of hematology
Published: June 15, 2025
Re-evaluation of current status and needs of long-term follow-up clinics for hematopoietic cell transplant survivors: results of a nationwide survey in Japan.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: June 03, 2025
Asciminib in patients with newly diagnosed chronic myeloid leukemia: results from the Japanese subgroup of ASC4FIRST.
Journal: International journal of hematology
Published: February 05, 2025
Post-transplant TKIs for Ph+ ALL: practices to date and clinical significance.
Journal: International journal of hematology
Published: November 18, 2024
Vedolizumab for prevention of lower-GI acute GVHD in the Japanese subgroup analysis of the phase 3 GRAPHITE study.
Journal: International journal of hematology
Published: September 27, 2024
Real-World Experience with Venetoclax Treatment for Newly-Diagnosed Acute Myeloid Leukemia in Japan (VENUS Study): An Interim Analysis Focusing on Neutropenia Management.
Journal: Oncology and therapy
Published: August 30, 2024
Asciminib in Patients With CML-CP Previously Treated With ≥ 2 Tyrosine Kinase Inhibitors: 96-Week Results From the Japanese Subgroup Analysis of the ASCEMBL Study.
Journal: International journal of hematology
Published: March 15, 2024
Last Updated: 09/26/2026